A soldier wounded in Korea in 1951 had better survival odds than soldiers wounded in World War II despite heavier casualties and harsher conditions. The difference was time. Mobile Army Surgical ...

A decade ago, entrepreneur PC Zhu was in the United States, starting up a Boston-based outfit helping biotech startups grow. Today he is in Shanghai, building one of the country’s most ambitious ...

No peeler needed here! Keeping the skin on adds flecks of color and a hearty texture to these mashed red potatoes. Marcia Kiesel, a former Food & Wine test kitchen supervisor, is an experienced chef ...

Panelists discuss how structured, multidisciplinary screening efforts can catch MASH earlier and prevent progression. Panelists discuss how proactive screening and diagnostic strategies can identify ...

Though butter and milk are common additions to mashed potatoes, our favorite recipe uses olive oil and Manchego cheese to achieve its silky texture and richness. Chefs and home cooks love garlic in ...

EXCLUSIVE: The 1962 song “Monster Mash,” which has become an annual Halloween +hit, is becoming an animated movie at Miramax. Miramax CEO Jonathan Glickman, who has been behind such haunted hits as ...

For years, MASH was where drug development dreams went to die. One trial after another failed. Companies bowed out. The field earned a reputation as one of biopharma’s most intractable challenges: a ...

Metabolic-associated steatohepatitis (MASH) happens when excess fat in the liver causes inflammation and scarring, or fibrosis. The condition is serious, and when left untreated it can lead to ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Oct 7, 2025 at 10:12 ...

There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio and its late-stage MASH drug, giving the Swiss pharmaceutical giant the ...

Roche dived into the metabolic dysfunction-associated steatohepatitis (MASH) space by agreeing to hand over up to $3.5 billion for 89bio and its phase-3-stage candidate for the fatty liver disease. At ...